Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Psychopharmacology|June 30, 2016
Cabergoline-induced manic episode: case reportRabia Nazik Yüksel, Zeynep Elyas Kaya, Nesrin Dilbaz, et al.
Nordic Journal of Psychiatry|March 10, 2018
Thiol/disulphide homeostasis in schizophrenia patients with positive symptomsKübranur Ünal, Gamze Erzin, Rabia Nazik Yüksel, et al.
Nordic Journal of Psychiatry|April 13, 2018
High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parametersRabia Nazik Yüksel, Irem Ekmekci Ertek, Asiye Uğraş Dikmen, et al.
Noro Psikiyatri Arsivi|December 20, 2021
Retrospective Evaluation of Cases Examined to Determine Criminal ResponsibilitiesŞahin Gürkan, Kazım Cihan Can, Hasan Kaya, et al.
Psychiatry Research|December 27, 2017
The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophreniaKubranur Ünal, Rabia Nazik Yüksel, Turan Turhan, et al.
Nordic Journal of Psychiatry|January 9, 2018
Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activityNeslihan Altunsoy, Rabia Nazik Yüksel, Merve Cingi Yirun, et al.
Nordic Journal of Psychiatry|July 6, 2022
Serum concentrations of aminoacylase 1 in schizophrenia as a potential biomarker: a case-sibling-control studyDiğdem Göverti, Rabia Nazik Yüksel, Hasan Kaya, et al.
Early Intervention in Psychiatry|January 27, 2023
Decreased serum levels of α-synuclein in patients with schizophrenia and their unaffected siblingsDiğdem Göverti, Nihan Büyüklüoğlu, Rabia Nazik Yüksel, et al.
Psychopharmacology|April 28, 2022
Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophreniaDiğdem Göverti, Nihan Büyüklüoğlu, Hasan Kaya, et al.
The Psychiatric Quarterly|March 12, 2020
Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected SiblingsRabia Nazik Yüksel, Diğdem Göverti, Aybeniz Civan Kahve, et al.
Pageof 2